Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Douglas A Michels. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Douglas A Michels har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:WST / West Pharmaceutical Services, Inc. | Director | 45 171 |
US:TYME / Tyme Technologies Inc | Director | 0 |
US:OSUR / OraSure Technologies, Inc. | President & CEO, Director | 660 861 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Douglas A Michels. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp OSUR / OraSure Technologies, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i OSUR / OraSure Technologies, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel OSUR / OraSure Technologies, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i OSUR / OraSure Technologies, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Douglas A Michels som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 1 071 | 45 171 | 2,43 | ||||
2024-04-25 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 564 | 44 100 | 1,30 | ||||
2023-04-27 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 616 | 43 536 | 1,44 | ||||
2022-09-16 |
|
4 | TYME |
TYME TECHNOLOGIES, INC.
Common Stock |
D - Sale to Issuer | −110 000 | 0 | −100,00 | ||||
2022-05-26 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 632 | 42 920 | 1,49 | ||||
2021-08-26 |
|
4 | TYME |
TYME TECHNOLOGIES, INC.
Director Stock Option - Option to buy |
A - Award | 88 000 | 88 000 | |||||
2021-05-06 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 577 | 42 288 | 1,38 | ||||
2020-09-03 |
|
4 | TYME |
TYME TECHNOLOGIES, INC.
Common Stock |
P - Purchase | 50 000 | 110 000 | 83,33 | 0,96 | 48 000 | 105 600 | |
2020-08-24 |
|
4 | TYME |
TYME TECHNOLOGIES, INC.
Director Stock Option - right to buy |
A - Award | 65 000 | 65 000 | |||||
2020-05-07 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 975 | 41 616 | 2,40 | ||||
2019-08-27 |
|
4 | TYME |
TYME TECHNOLOGIES, INC.
Director Stock Option - Right to Buy |
A - Award | 50 000 | 50 000 | |||||
2019-05-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 1 565 | 27 277 | 6,09 | ||||
2019-02-19 |
|
4 | TYME |
TYME TECHNOLOGIES, INC.
Common Stock |
P - Purchase | 20 000 | 60 000 | 50,00 | 3,26 | 65 200 | 195 600 | |
2019-01-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 255 | 12 998 | 2,00 | 98,03 | 24 998 | 1 274 149 | |
2018-10-03 |
|
4 | TYME |
TYME TECHNOLOGIES, INC.
Director Stock Option - right to buy |
A - Award | 45 833 | 145 833 | 45,83 | ||||
2018-10-03 |
|
4 | TYME |
TYME TECHNOLOGIES, INC.
Director Stock Option - right to buy |
A - Award | 100 000 | 100 000 | |||||
2018-10-03 | 3 | TYME |
TYME TECHNOLOGIES, INC.
Common Stock |
80 000 | ||||||||
2018-10-03 | 3 | TYME |
TYME TECHNOLOGIES, INC.
Common Stock |
80 000 | ||||||||
2018-10-03 | 3 | TYME |
TYME TECHNOLOGIES, INC.
Common Stock |
80 000 | ||||||||
2018-10-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 203 | 12 743 | 1,62 | 123,74 | 25 119 | 1 576 762 | |
2018-08-01 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 272 | 12 540 | 2,22 | 99,29 | 26 988 | 1 245 051 | |
2018-08-01 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 300 | 12 268 | 2,50 | 86,72 | 25 991 | 1 063 858 | |
2018-08-01 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 268 | 11 968 | 2,29 | 99,16 | 26 603 | 1 186 749 | |
2018-05-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 1 824 | 25 607 | 7,67 | ||||
2018-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −56 078 | 660 861 | −7,82 | 16,80 | −941 830 | 11 099 160 | |
2018-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −8 736 | 716 939 | −1,20 | 21,00 | −183 456 | 15 055 719 | |
2018-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
A - Award | 36 615 | 725 675 | 5,31 | ||||
2018-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −27 985 | 689 060 | −3,90 | 21,64 | −605 735 | 14 914 704 | |
2018-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | −3 090 | 717 045 | −0,43 | 19,39 | −59 915 | 13 903 503 | |
2017-10-06 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −22 923 | 720 135 | −3,08 | 23,00 | −527 229 | 16 563 105 |
2017-10-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 260 | 11 700 | 2,27 | 96,33 | 25 000 | 1 127 036 | |
2017-10-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −25 000 | 743 058 | −3,25 | 22,55 | −563 712 | 16 754 843 |
2017-07-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 265 | 11 423 | 2,37 | 94,39 | 25 000 | 1 078 233 | |
2017-06-29 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock options |
M - Exercise | −89 541 | 82 378 | −52,08 | ||||
2017-06-29 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock options |
M - Exercise | −75 000 | 0 | −100,00 | ||||
2017-06-29 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock options |
M - Exercise | −125 954 | 0 | −100,00 | ||||
2017-06-29 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −89 541 | 768 058 | −10,44 | 16,28 | −1 457 817 | 12 504 752 |
2017-06-29 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −75 000 | 857 599 | −8,04 | 16,67 | −1 250 475 | 14 298 748 |
2017-06-29 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −125 954 | 932 599 | −11,90 | 17,13 | −2 157 970 | 15 978 219 |
2017-06-29 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 89 541 | 1 058 553 | 9,24 | 9,30 | 833 179 | 9 849 836 | |
2017-06-29 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 75 000 | 969 012 | 8,39 | 11,30 | 847 125 | 10 944 991 | |
2017-06-29 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 125 954 | 894 012 | 16,40 | 11,30 | 1 422 650 | 10 097 866 | |
2017-05-11 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock options |
M - Exercise | −195 833 | 0 | −100,00 | ||||
2017-05-11 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock options |
M - Exercise | −13 967 | 0 | −100,00 | ||||
2017-05-11 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | −209 800 | 768 058 | −21,46 | 15,01 | −3 149 098 | 11 528 551 | |
2017-05-11 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 195 833 | 977 858 | 25,04 | 5,71 | 1 119 166 | 5 588 361 | |
2017-05-11 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 13 967 | 782 025 | 1,82 | 7,04 | 98 398 | 5 509 366 | |
2017-05-09 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock options |
M - Exercise | −167 916 | 13 967 | −92,32 | ||||
2017-05-09 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock options |
M - Exercise | −79 738 | 0 | −100,00 | ||||
2017-05-09 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | −167 916 | 768 058 | −17,94 | 15,09 | −2 533 852 | 11 589 995 | |
2017-05-09 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 167 916 | 935 974 | 21,86 | 7,04 | 1 182 968 | 6 593 937 | |
2017-05-09 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | −79 738 | 768 058 | −9,41 | 15,09 | −1 203 246 | 11 589 995 | |
2017-05-09 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 79 738 | 847 796 | 10,38 | 6,62 | 528 264 | 5 616 648 | |
2017-05-09 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock options |
M - Exercise | −113 562 | 79 738 | −58,75 | ||||
2017-05-09 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | −113 562 | 768 058 | −12,88 | 15,06 | −1 710 244 | 11 566 953 | |
2017-05-09 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 113 562 | 881 620 | 14,79 | 6,62 | 752 348 | 5 840 732 | |
2017-05-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 1 697 | 23 717 | 7,71 | ||||
2017-04-04 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 306 | 11 143 | 2,82 | 81,69 | 25 000 | 910 264 | |
2017-02-13 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock option |
M - Exercise | −102 365 | 0 | −100,00 | ||||
2017-02-13 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock option |
M - Exercise | −90 990 | 0 | −100,00 | ||||
2017-02-13 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −102 365 | 768 058 | −11,76 | 10,27 | −1 051 186 | 7 887 188 |
2017-02-13 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −90 990 | 870 423 | −9,46 | 10,14 | −923 084 | 8 830 354 |
2017-02-13 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 102 365 | 961 413 | 11,92 | 5,19 | 531 274 | 4 989 733 | |
2017-02-13 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 90 990 | 859 048 | 11,85 | 2,80 | 255 227 | 2 409 630 | |
2017-02-06 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −19 208 | 768 058 | −2,44 | 8,84 | −169 799 | 6 789 633 | |
2017-02-02 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
A - Award | 77 695 | 787 266 | 10,95 | ||||
2017-02-02 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −15 837 | 709 571 | −2,18 | 8,87 | −140 474 | 6 293 895 | |
2017-02-02 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | −6 490 | 725 408 | −0,89 | 8,60 | −55 846 | 6 242 136 | |
2017-01-04 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 293 | 10 820 | 2,79 | 85,20 | 25 000 | 921 885 | |
2016-12-14 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Non-qualified stock options |
M - Exercise | −56 250 | 0 | −100,00 | ||||
2016-12-14 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Non-qualified stock options |
M - Exercise | −15 216 | 0 | −100,00 | ||||
2016-12-14 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −56 250 | 731 898 | −7,14 | 9,08 | −510 750 | 6 645 634 |
2016-12-14 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −15 216 | 788 148 | −1,89 | 9,02 | −137 248 | 7 109 095 |
2016-12-14 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 56 250 | 803 364 | 7,53 | 8,06 | 453 094 | 6 471 097 | |
2016-12-14 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 15 216 | 747 114 | 2,08 | 8,28 | 125 912 | 6 182 368 | |
2016-12-12 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Non-qualified stock options |
M - Exercise | −23 891 | 15 216 | −61,09 | ||||
2016-12-12 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
O - Other | X | −23 891 | 731 898 | −3,16 | 9,01 | −215 258 | 6 594 401 |
2016-12-12 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 23 891 | 755 789 | 3,26 | 8,28 | 197 698 | 6 254 154 | |
2016-11-28 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Non-qualified stock options |
M - Exercise | −5 893 | 39 107 | −13,10 | ||||
2016-11-28 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −142 | 731 898 | −0,02 | 9,01 | −1 279 | 6 594 401 |
2016-11-28 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −5 751 | 732 040 | −0,78 | 9,03 | −51 932 | 6 610 321 |
2016-11-28 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 142 | 737 791 | 0,02 | 8,28 | 1 175 | 6 105 221 | |
2016-11-28 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 5 751 | 737 649 | 0,79 | 8,28 | 47 590 | 6 104 045 | |
2016-11-28 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −25 000 | 731 898 | −3,30 | 9,02 | −225 500 | 6 601 720 |
2016-10-04 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 337 | 10 493 | 3,32 | 74,12 | 25 000 | 777 775 | |
2016-09-28 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −25 000 | 756 898 | −3,20 | 8,22 | −205 525 | 6 222 458 |
2016-07-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 311 | 10 156 | 3,16 | 75,06 | 23 333 | 762 322 | |
2016-05-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2 262 | 21 882 | 11,53 | ||||
2016-04-04 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 290 | 9 828 | 3,04 | 68,91 | 20 000 | 677 278 | |
2016-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −15 666 | 781 898 | −1,96 | 5,35 | −83 813 | 4 183 154 | |
2016-02-02 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
A - Award | 119 490 | 797 564 | 17,62 | ||||
2016-02-02 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −7 263 | 678 074 | −1,06 | 5,37 | −39 002 | 3 641 257 | |
2016-02-02 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | −9 824 | 685 337 | −1,41 | 5,70 | −55 997 | 3 906 421 | |
2016-01-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 287 | 9 518 | 3,10 | 61,07 | 17 500 | 581 266 | |
2015-12-18 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | −6 600 | 695 161 | −0,94 | 8,50 | −56 100 | 5 908 868 | |
2015-10-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 319 | 9 214 | 3,59 | 54,83 | 17 500 | 505 177 | |
2015-07-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 301 | 8 878 | 3,51 | 58,13 | 17 500 | 516 093 | |
2015-05-07 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2 448 | 19 470 | 14,38 | ||||
2015-04-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 293 | 8 541 | 3,56 | 59,66 | 17 500 | 509 576 | |
2015-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock option |
A - Award | 171 919 | 171 919 | |||||
2015-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
A - Award | 59 934 | 701 761 | 9,34 | ||||
2015-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −9 397 | 641 827 | −1,44 | 9,30 | −87 439 | 5 972 200 | |
2015-02-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −10 708 | 651 224 | −1,62 | 9,13 | −97 764 | 5 945 675 | |
2015-01-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 325 | 8 248 | 4,10 | ||||
2014-12-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock option |
M - Exercise | −12 597 | 0 | −100,00 | ||||
2014-12-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −7 353 | 661 932 | −1,10 | 9,59 | −70 515 | 6 347 928 | |
2014-12-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 12 597 | 669 285 | 1,92 | 5,60 | 70 518 | 3 746 657 | |
2014-10-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 389 | 7 906 | 5,18 | ||||
2014-07-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 416 | 7 498 | 5,88 | 42,02 | 17 500 | 315 060 | |
2014-07-01 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −2 056 | 656 688 | −0,31 | 8,61 | −17 702 | 5 654 084 | |
2014-05-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 3 016 | 16 874 | 21,76 | ||||
2014-04-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 406 | 7 063 | 6,10 | ||||
2014-04-01 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −2 056 | 658 744 | −0,31 | 7,93 | −16 304 | 5 223 840 | |
2014-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock option |
A - Award | 254 054 | 254 054 | |||||
2014-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
A - Award | 88 820 | 660 800 | 15,53 | ||||
2014-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −19 760 | 571 980 | −3,34 | 5,72 | −112 928 | 3 268 866 | |
2014-02-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | −8 400 | 591 740 | −1,40 | 6,66 | −55 944 | 3 940 988 | |
2014-01-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 357 | 6 644 | 5,67 | ||||
2014-01-02 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −2 056 | 600 140 | −0,34 | 6,16 | −12 655 | 3 693 862 | |
2013-10-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 429 | 6 274 | 7,35 | ||||
2013-10-01 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −2 056 | 602 196 | −0,34 | 6,10 | −12 531 | 3 670 385 | |
2013-07-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 249 | 2 915 | 9,32 | ||||
2013-07-02 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −2 056 | 604 252 | −0,34 | 3,96 | −8 142 | 2 392 838 | |
2013-05-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2 003 | 6 868 | 41,17 | ||||
2013-04-02 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −2 056 | 606 308 | −0,34 | 5,32 | −10 928 | 3 222 527 | |
2013-04-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 270 | 2 659 | 11,30 | ||||
2013-02-04 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock option |
A - Award | 181 883 | 181 883 | |||||
2013-02-04 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | 3 970 | 9 370 | 73,52 | ||||
2013-02-04 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | −3 970 | 608 364 | −0,65 | ||||
2013-02-04 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | −3 970 | 608 364 | −0,65 | ||||
2013-02-04 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
A - Award | 62 456 | 616 304 | 11,28 | ||||
2013-02-04 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −12 795 | 553 848 | −2,26 | 7,04 | −90 141 | 3 901 859 | |
2013-01-29 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −6 845 | 566 643 | −1,19 | 6,92 | −47 367 | 3 921 170 | |
2013-01-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 323 | 2 381 | 15,67 | ||||
2013-01-02 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −2 647 | 573 488 | −0,46 | 6,88 | −18 211 | 3 945 597 | |
2012-10-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −2 647 | 576 135 | −0,46 | 11,20 | −29 633 | 6 449 831 | |
2012-10-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 236 | 2 052 | 12,99 | ||||
2012-07-11 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Non-qualified stock option |
M - Exercise | −53 497 | 12 597 | −80,94 | ||||
2012-07-11 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Incentive stock option |
M - Exercise | −1 406 | 0 | −100,00 | ||||
2012-07-11 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Non-qualified stock option |
M - Exercise | −7 197 | 0 | −100,00 | ||||
2012-07-11 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −62 100 | 578 782 | −9,69 | 13,64 | −847 044 | 7 894 586 |
2012-07-11 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 54 903 | 640 882 | 9,37 | 5,60 | 307 347 | 3 587 657 | |
2012-07-11 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 7 197 | 585 979 | 1,24 | 7,76 | 55 885 | 4 550 127 | |
2012-07-06 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Non-qualified stock option |
M - Exercise | −60 000 | 7 197 | −89,29 | ||||
2012-07-06 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −60 000 | 578 782 | −9,39 | 13,14 | −788 160 | 7 602 880 |
2012-07-06 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 60 000 | 638 782 | 10,37 | 7,76 | 465 900 | 4 960 142 | |
2012-07-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Non-qualified stock option |
M - Exercise | −150 021 | 67 197 | −69,06 | ||||
2012-07-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −150 021 | 578 782 | −20,58 | 12,95 | −1 942 622 | 7 494 648 |
2012-07-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 150 021 | 728 803 | 25,92 | 7,76 | 1 164 913 | 5 659 155 | |
2012-07-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Non-qaulified stock option |
M - Exercise | −60 000 | 217 218 | −21,64 | ||||
2012-07-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −60 000 | 578 782 | −9,39 | 12,10 | −726 000 | 7 003 262 |
2012-07-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 60 000 | 638 782 | 10,37 | 7,76 | 465 900 | 4 960 142 | |
2012-07-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −2 647 | 578 782 | −0,46 | 11,26 | −29 805 | 6 517 085 | |
2012-07-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 289 | 1 809 | 19,03 | ||||
2012-05-18 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock option |
M - Exercise | −47 782 | 277 218 | −14,70 | ||||
2012-05-18 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −47 782 | 581 429 | −7,59 | 12,08 | −577 302 | 7 024 825 |
2012-05-18 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 47 782 | 629 211 | 8,22 | 7,76 | 371 027 | 4 885 823 | |
2012-05-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2 459 | 4 805 | 104,80 | ||||
2012-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock option |
M - Exercise | −23 488 | 325 000 | −6,74 | ||||
2012-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Incentive stock option |
M - Exercise | −1 512 | 0 | −100,00 | ||||
2012-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −25 000 | 581 429 | −4,12 | 11,47 | −286 785 | 6 669 805 |
2012-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 25 000 | 606 429 | 4,30 | 7,76 | 194 125 | 4 708 921 | |
2012-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Incentive stock option |
M - Exercise | −25 000 | 1 512 | −94,30 | ||||
2012-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −25 000 | 581 429 | −4,12 | 11,44 | −286 078 | 6 653 350 |
2012-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 25 000 | 606 429 | 4,30 | 7,76 | 194 125 | 4 708 921 | |
2012-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −3 073 | 581 429 | −0,53 | 11,42 | −35 094 | 6 639 919 | |
2012-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Incentive stock option |
M - Exercise | −25 000 | 26 512 | −48,53 | ||||
2012-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
S - Sale | X | −25 000 | 584 502 | −4,10 | 11,53 | −288 210 | 6 738 373 |
2012-04-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
M - Exercise | 25 000 | 609 502 | 4,28 | 7,76 | 194 125 | 4 732 783 | |
2012-04-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 316 | 1 514 | 26,36 | ||||
2012-02-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Nonqualified stock options |
A - Award | 200 954 | 200 954 | |||||
2012-02-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
A - Award | 36 654 | 584 502 | 6,69 | ||||
2012-02-03 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −10 517 | 547 848 | −1,88 | 11,30 | −118 790 | 6 187 943 | |
2012-01-27 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −7 526 | 558 365 | −1,33 | 10,93 | −82 259 | 6 102 929 | |
2012-01-25 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −6 727 | 565 891 | −1,17 | 11,36 | −76 452 | 6 431 351 | |
2012-01-25 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | 2 700 | 5 400 | 100,00 | ||||
2012-01-25 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | −2 700 | 572 618 | −0,47 | ||||
2012-01-25 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | −2 700 | 572 618 | −0,47 | ||||
2012-01-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
F - Taxes | −2 697 | 588 918 | −0,46 | 9,39 | −25 325 | 5 529 940 | |
2012-01-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | 2 700 | 2 700 | |||||
2012-01-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | −2 700 | 578 018 | −0,46 | ||||
2012-01-05 |
|
4 | OSUR |
ORASURE TECHNOLOGIES INC
Common stock |
G - Gift | −8 200 | 580 718 | −1,39 | ||||
2012-01-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 435 | 1 193 | 57,41 | 37,93 | 16 500 | 45 238 | |
2004-06-24 | 3 | OSUR |
ORASURE TECHNOLOGIES INC
No securities are beneficially owned. |
0 |